Segments - Bone & Joint Health Supplements Market by Type (Calcium, Omega-3 Fatty Acids, Vitamin D, Vitamin K, Glucosamine-Chondroitin, Collagen, and Others), Form (Capsules, Tablets/Pills, Liquid, and Powder), End-user (Infants, Adults, Senior Citizen, and Pregnant Women), Distribution Channel (Pharmacies & Drug Stores, Health & Beauty Stores, Supermarkets/Hypermarkets, and Online), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
The global bone & joint health supplements market size was valued at USD 10.8 Bn in 2021 and is expected to surpass USD 18.9 Bn by 2030, expanding at a CAGR of 8.2% during the forecast period, 2022–2030. The growth of the market is attributed to the wide prevalence of bone and joint diseases among the older population globally, rising disposable income, and increasing demand for dietary supplements for infants to ensure strong and healthy bone development.
Bone and joint health supplements are dietary supplements that help in strengthening the bones, easing joint movement, and preventing bone fractures caused by weak bones. The condition of bone weakness is primarily caused by low calcium intake and inadequate vitamin consumption.
Several lifestyle diseases such as arthritis, osteoporosis, and rheumatoid arthritis widely prevail among the older population due to nutritional deficiencies of omega-3 fatty acids, vitamin K, glucosamine-chondroitin, and collagen. These bone and joint supplements contain key nutrients such as amino acids, minerals, and vitamins, and regular intake of these supplements prevents bone fractures and joint issues, which normally leads to the overall well-being of consumers.
Vitamin D deficiency is widespread among the baby boomers globally, and the US alone has 70% of the children affected by the deficiency. With the increasing demand for joint health supplements globally, several manufacturers are developing a range of easy-to-consume and effective absorption supplements including powder- and liquid-based capsules and tablets to meet the need of different groups of the population including infants, adults, and the aging population.
The COVID-19 pandemic induced an economic crisis globally but accelerated the overall dietary supplements market, as people became increasingly aware of the roles and health benefits of having a strong immune system to protect from diseases. Nutraceutical products with immunity-boosting ingredients such as calcium, vitamins, and collagen were in high demand during the pandemic, following the instructions from doctors and healthcare professionals to boost the immunity.
The demand for vitamins surged significantly in order to adopt a healthy lifestyle, and thus, partly contributing to the increasing expansion of the market. However, the sudden disruption in the supply chain and lack of R&D funding for clinical trials remained key challenges for market growth during the pandemic.
The research report presents a complete overview of the market dynamics by focusing on the current market trends, existing drivers, growth opportunities, and emerging challenges that can shape the outcome or overall performance of the market during the forecast period, 2022 to 2030.
The report finds that the rising geriatric population globally is one of the key market trends. The aging population is the largest target audience for the supplement market, as this demographic group is highly susceptible to bone injuries and joint problems. As per the 2019 report published by the United Nations (UN), the total number of people who attained the age of 65 years globally was more than 703 million that year, and the number is likely to reach 1.5 billion by 2050. The increasing elderly population worldwide presents a crucial factor driving the market.
The condition of bone weakness, osteoporosis, and rheumatoid arthritis has highly prevailed among senior citizens and infants as well. According to a study by Cleveland Clinic in April 2020, more than 200 million globally were the victims of osteoporosis and the US alone had a pool of 54 million osteoporosis patients.
The study further states that over two million bone fracture cases are registered every year due to the disorder and the rate of osteoporosis development among women is more likely than in men. Among the old population, the condition of bone fractures is likely to occur once in four men and one in two women globally. In the US, over 12 million population are at high risk of developing osteoporosis.
Rheumatoid arthritis is a major autoimmune disease that has affected a hundred of million people across the globe, especially among the aging population. To meet the growing demand from end-users, key manufacturers of health supplements focus on the development of new supplement drinks and orally-consumed products to boost the bone health of patients.
Clinical trials for the development of bone supplements are highly expensive processes, as the final approval of nutraceutical products needs to go through a series of laboratory trials and testing. Moreover, the lack of commercialization of existing health supplement products, especially in developing countries acts as a major restraint that discourages the development of new health supplements. Developing a novel supplement requires high investments in R&D programs, which presents another key factor hampering the market.
The nutritional supplements or dietary supplements industry is subject to competitive regulations change and frequent change in nutritional care standards presents a key challenge to the market. Various new regulations and mandates regarding the quality, nutritional level, and safety of health supplements set by major regulators such as the US Food and Drug Administration (FDA) and the Food Safety and Standards Authority of India (FSSAI) often pose major challenges to the manufacturers.
The increasing health-conscious population, especially in developing countries opens up immense growth opportunities in the market. With government initiatives in healthcare development and rising health awareness, consumers are gradually shifting toward dietary supplements and personalized nutrition to prevent lifestyle diseases and nutritional deficiencies such as calcium, amino acids, and vitamin D.
Doctors and healthcare professionals play a crucial role in increasing the use of bone and joint health supplements by consumers due to their constant supervision for better supplement alternatives. In most developed regions such as North America and Europe, the rate of consumption of health supplements is relatively high due to the presence of a large pool of the population, who are aware of the benefits of dietary supplements.
The report on the global bone & joint health supplements market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Bone & Joint Health Supplements Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2019–2020 |
Forecast Period |
2022–2030 |
Segmentation |
Type (Calcium, Omega-3 Fatty Acids, Vitamin D, Vitamin K, Glucosamine-Chondroitin, Collagen, and Others), Form (Capsules, Tablets/Pills, Liquid, and Powder), End-user (Infants, Adults, Senior Citizen, and Pregnant Women), and Distribution Channel (Pharmacies & Drug Stores, Health & Beauty Stores, Supermarkets/Hypermarkets, and Online) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Nature's Bounty; Bayer AG; ADM; BASF SE; Procter & Gamble; Amway (Nutrilite); GSK-Pfizer; Abbott Laboratories; A&Z Pharmaceutical; Koninklijke DSM N.V.; Herbalife International; Nutramax Laboratories, Inc.; NOW Health Group, Inc.; Shanxi Zhendong Pharmaceutical; Bio-Tech Pharmacal Inc.; Seroyal International Inc.; NutriGold Inc.; Swisse; and Harbin Pharmaceutical Group |
Based on type, the global market is divided into calcium, omega-3 fatty acids, vitamin D, vitamin K, glucosamine-chondroitin, collagen, and others. The calcium segment constituted a key market share in 2021 and is projected to expand at a CAGR of 8.1% during the forecast period owing to the growing demand for calcium supplements to meet the rising demand from patients having hypocalcemia and calcium deficiency.
Low calcium levels lead to various health conditions such as extreme fatigue, dizziness, and insomnia, and the lack of sufficient consumption of dairy products by infants and adults causes calcium deficiency. Vitamin D plays an important role in the absorption of calcium and the lack of calcium supplements can be caused due to the deficiency, which may lead to lifestyle diseases.
The glucosamine-chondroitin segment has huge growth potential and is anticipated to register a steady growth rate in the coming years owing to the increasing demand for glucosamine-chondroitin supplements among patients having arthritis. The combination supplement of the two ingredient types provides cushioning to the joints and relieves arthritis pain, as it can slow down cartilage deterioration.
In terms of form, the market is segmented into capsules, tablets/pills, liquid, and powder. The capsules segment size accounted for a large market share in 2021 and is anticipated to expand at a CAGR of 8.1% during the forecast period owing to the wide availability of capsule-based bone and joint health supplements for adults and elders.
Nutrients in capsule form can be easily dissolved and absorbed better in the body as compared to other forms of supplements including tablets. Rising consumer preferences for capsule-based health supplements are influenced by factors such as easy to consume, easily dissolvable, and effective results of the nutrients.
The tablets segment has enormous growth potential and is expected to hold a key market share in the coming years owing to the abundant availability of various tablets for optimal nutrition and the high shelf-life of the supplement type. Various types of nutrients including omega-3 fatty, amino acids, and vitamins are available in tablet-based health supplements, due to advantages such as easy storage and easy packaging.
On the basis of end-user, the global market is segregated into infants, adults, senior citizen, and pregnant women. The senior citizen segment held a dominant market revenue share, which was worth USD 4.9 billion in 2021, and is anticipated to expand at a robust CAGR during the forecast period due to the wide prevalence of bone and joint problems among elderly groups globally.
Increasing demand for bone supplements from the rising elderly population and the presence of a large number of the health-conscious senior population, especially in developed countries are key factors fueling the segment. In the US, a large number of older people often consume joint health supplements, available in the form of liquid and a pill.
The infants segment is anticipated to account for a major market share in the coming years owing to the increasing demand for health supplements such as vitamins and minerals among infants to have strong bones. Furthermore, the high prevalence of joint-related diseases such as rheumatoid arthritis and osteoarthritis among the infant group and the wide availability of powder- and liquid-based health supplements for easy consumption by infants are likely to aid in segment growth.
Based on distribution channel, the market is categorized as pharmacies & drug stores, health & beauty stores, supermarkets/hypermarkets, and online. The supermarkets/hypermarkets segment accounted for a major market share in 2021 and is projected to expand at a significant growth rate during the forecast period owing to the rapid expansion of the supermarket chains and the wide availability of health supplements in these stores.
To expand the sale of the products and consumer base, key manufacturers of health supplements are increasingly attached to supermarkets/hypermarkets and offer a range of their products through these distribution channels. The online segment is a fast-growing distribution channel and is expected to register a CAGR of 6.7% during the forecast period.
The segment growth is attributed to the rising consumers’ preference for online shopping of health supplements as e-commerce platforms offer these products at a cheaper price as compared to traditional retailers. Moreover, the door-step delivery facilities and easy return processes offered by online platforms to enhance customers’ experience are other key factors boosting the segment growth.
In terms of region, the global bone & joint health supplements market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a dominant market share in 2021 and the market in the region was valued at around USD 3.5 billion in the same year. The US market size accounted for around 70% of the regional market share in North America in 2021.
The market size in North America is projected to register a CAGR of 7.6% during the forecast period owing to the presence of a large number of senior citizens and wide consumer awareness regarding the benefits of various health supplements among the population. Moreover, the presence of several key global players and massive R&D programs for health supplements in North America, especially in the US play another crucial factor in boosting the regional market.
The market in Asia Pacific is projected to register a CAGR of 7.4% during the forecast period owing to the rising health-conscious population, increasing disposable income, and growing spending on health supplements.
Moreover, the rising governments’ initiatives for healthcare awareness and rapid expansion of pharmaceutical & drug stores are further boosting the market in Asia Pacific. In the region, China has one of the largest markets for joint health supplements and the market of the country is projected to reach USD 3 billion by 2030.
The global bone & joint health supplements market has been segmented on the basis of
Key players competing in the global market are Nature's Bounty; Bayer AG; ADM; BASF SE; Procter & Gamble; Amway (Nutrilite); GSK-Pfizer; Abbott Laboratories; A&Z Pharmaceutical; Koninklijke DSM N.V.; Herbalife International; Nutramax Laboratories, Inc.; NOW Health Group, Inc.; Shanxi Zhendong Pharmaceutical; Bio-Tech Pharmacal Inc.; Seroyal International Inc.; NutriGold Inc.; Swisse; and Harbin Pharmaceutical Group.
These major companies have adopted a series of business development strategies including merger and acquisition, entering into partnerships and collaboration, product launches, and production capacity expansion to expand their consumer base and enhance their market share.
For instance,
The key players in the market are Nature's Bounty; Bayer AG; ADM; BASF SE; Procter & Gamble; Amway (Nutrilite); GSK-Pfizer; Abbott Laboratories; A&Z Pharmaceutical; Koninklijke DSM N.V.; and Herbalife International.
For regional analysis, North America held a dominant market share in 2021 and the market size in the region was valued at around USD 3.5 billion in the same year.
The key drivers of the market include the wide prevalence of bone & joint problems among the older population globally and the increasing demand for dietary supplements for infants to ensure strong and healthy bone development.
The senior citizen segment held a dominant market revenue share, which was worth USD 4.9 billion in 2021 and is anticipated to exhibit a robust CAGR during the forecast period.
The global bone & joint health supplements market size was valued at USD 10.8 billion in 2021 and is expected to surpass USD 18.9 billion by 2030.